Technology

Prezent Vivo examines the limits of AI in scientific communication at Articulate 2026

Artificial intelligence is becoming increasingly common across the life sciences industry, but turning adoption into measurable business value remains a challenge. For pharmaceutical and biotechnology companies, the difficulty extends beyond.

  • 0
  • 50 views

Rental housing operators face growing technology demands as OPTECH 2026 approaches

Managing rental housing increasingly requires more than maintaining properties and collecting rent. Operators must also coordinate digital systems, manage cybersecurity risks, comply with changing regulations and deliver consistent resident experiences..

  • 0
  • 44 views

Why healthcare app developers are looking beyond basic messaging infrastructure

Building a healthcare application involves more than creating an interface for patients and providers. Development teams must also account for sensitive information, reliable communication, integration with existing systems, and the.

  • 0
  • 28 views

Before, during, and after the storm: 10 AI companies utilities rely on

Every big storm ends with a scorecard. Climate central found that major weather-related outages averaged 78% more per year in 2011 through 2021 than in the decade before in the.

  • 0
  • 65 views

The next AI opportunity may be turning workers into robot powered entrepreneurs

The debate over artificial intelligence and robotics has largely focused on one question: What jobs will machines eliminate? That, ultimately, may be the wrong question to ask. As robots become.

  • 0
  • 93 views

Accelerating life sciences with AI-native communications to improve patient outcomes

In the high-stakes world of life sciences, effectively communicating scientific breakthroughs is just as critical as the discoveries themselves. However, the stringent need for accuracy and academic rigor has traditionally.

  • 0
  • 165 views

Prezent Vivo and Nested Knowledge team up to reinvent competitive intelligence for life sciences

The partnership combines AI-powered evidence synthesis and scientific communications to help pharmaceutical teams move from information overload to actionable insights.

  • 0
  • 283 views

Debbie flips the loyalty model with Rewards 2.0, pays cash for savings and debt payoff 

Personal finance platform Debbie has launched Rewards 2.0 and announced a $5.3 million seed round, introducing a points system that awards users for saving money and paying down debt in.

  • 0
  • 1,120 views

These Generative AI Consulting Firms are Fueling Full-Scale Enterprise Adoption in 2026 

In 2026, GenAI has moved beyond experimentation into full-scale enterprise adoption. In fact, a new report from OpenAI suggests a new era of enterprise adoption is already well underway. The.

  • 0
  • 677 views

Biotech startup ImmuneBridge unlocks cell therapy platform for partners, secures $7.7M seed extension 

San Francisco-based ImmuneBridge has announced a pivotal expansion: the company’s cell therapy screening and manufacturing platform, previously used only for its internal pipeline, will now be accessible to external therapeutic.

  • 0
  • 1,605 views